Latest Listings And Ipos News

Page 3 of 342
Skin Elements Limited reported a $4.01 million loss for the half-year ending December 2025, alongside a 41% revenue drop, while securing $2.5 million in fresh capital to advance its proprietary SE Formula biotechnology products.
Ada Torres
Ada Torres
27 Feb 2026
Clime Investment Management reports a strong half-year operating profit surge and proposes a fully franked interim dividend, while streamlining its business to target sophisticated investors.
Claire Turing
Claire Turing
27 Feb 2026
Atomos Limited has reported a profitable first half of FY26 with revenue up 28%, driven by strong sales and cost discipline. The company reaffirms its full-year guidance, anticipating further growth and positive cash flow in the second half.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Clarity Pharmaceuticals has reported a steep 136% increase in its half-year loss to $55.6 million, alongside the closure of its European subsidiary, signaling a challenging period for the ASX-listed biotech.
Ada Torres
Ada Torres
27 Feb 2026
Terra Metals has raised $85 million through an institutional placement to fast-track exploration and development of its promising Southwest Prospect within the Dante Project in Western Australia.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Kina Securities Limited reported a 20% increase in statutory net profit after tax to PGK 120.7 million for 2025, driven by strong revenue growth and loan book expansion. The bank declared a higher final dividend and anticipates continued earnings growth in 2026 amid favourable economic conditions and tax cuts.
Claire Turing
Claire Turing
27 Feb 2026
6K Additive, a US-based metal powder innovator, reports a 3.85% revenue dip to US$17.7 million and narrows net loss to US$17.9 million in its first ASX-listed year. The company plans a fivefold capacity expansion backed by significant government grants and a US$27.4 million loan.
Victor Sage
Victor Sage
27 Feb 2026
Associate Global Partners Limited reported a significantly reduced half-year loss and modest growth in funds under management, underpinned by strong inflows and strategic capital raising.
Claire Turing
Claire Turing
27 Feb 2026
Anteris Technologies Global Corp. posted a $94.2 million loss for 2025 amid a 29% revenue decline, while progressing its pivotal DurAVR THV clinical trial and securing $320 million in early 2026 financings.
Ada Torres
Ada Torres
27 Feb 2026
Metals X Limited reported a robust 2025 financial year with revenue up 30% to $285 million, driven by higher tin prices despite a slight dip in production. The company is advancing its key growth project, Rentails, targeting a final investment decision in late 2026.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Hubify has completed a strategic $250,000 placement at a striking 425% premium to fund its AI-first growth strategy, including a key partnership with HubLab to deliver AI-powered ICT and cybersecurity services.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Auric Mining has exceeded its 2026 gold production budgets at the Munda Starter Pit, delivering strong early results that validate the economic potential of the larger Munda Main Pit.
Maxwell Dee
Maxwell Dee
27 Feb 2026